Tuesday, February 13, 2018
The business combination of Aviragen Therapeutics, Inc. (AVIR) and Vaxart, Inc. closed today, Tuesday, February 13, 2018. As a result the common stock of Aviragen Therapeutics, Inc. will undergo a one-for-eleven (1-11) reverse stock split, change of name, symbol, and CUSIP number.
The details of the name, symbol, & CUSIP changes are follows:
If you would like to register as a market maker in VXRT, contact Nasdaq Trading Services at +1 212 231 5100.
Email Alert Subscriptions:
Nasdaq offers customers the ability to self select news delivery across various Nasdaq markets. Create and maintain a profile for updating alert preferences and contact information. Visit the enrollment form on the Nasdaq Trader website and sign up today! Please note that if you choose to unsubscribe from an email list, you may no longer receive potentially critical emails from the NASDAQ Stock Market regarding Nasdaq's trading and data products, regulatory issues or marketplace initiatives.
Nasdaq (Nasdaq: NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 90 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to approximately 3,900 total listings with a market value of approximately $13 trillion. To learn more, visit: business.nasdaq.com.